Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease
about
Dynamic Trk and G Protein Signalings Regulate Dopaminergic Neurodifferentiation in Human Trophoblast Stem CellsProtective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity.Identifying rare and common disease associated variants in genomic data using Parkinson's disease as a model.The role of microRNAs in human neural stem cells, neuronal differentiation and subtype specificationBack to the tubule: microtubule dynamics in Parkinson's disease.Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signalingLiver X receptors and cholesterol metabolism: role in ventral midbrain development and neurodegeneration.Generating CNS organoids from human induced pluripotent stem cells for modeling neurological disorders.A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway.Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson's disease.Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease.Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.Activation of the Wnt Pathway by Small Peptides: Rational Design, Synthesis and Biological Evaluation.Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson's Disease via Up-regulation of the Wnt/β-Catenin Pathway.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.Evolutionary Rewiring of Human Regulatory Networks by Waves of Genome Expansion.miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation.Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson's Disease.The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation
P2860
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
P248
Q28551183-3549EBFA-CADC-4016-BCCE-E48B8216B220Q29347547-C24CABCC-46CD-4180-A053-4E61AD6F59FCQ30846819-12ED5518-AC51-482A-9C3D-9495102D5580Q34828148-C0601405-23ED-4465-847C-CE98F825D6B1Q37590635-1087002A-D8B6-42D5-940D-4DCE7D127873Q37595673-3D557383-11AB-4C2C-8624-992C0A045B80Q38534041-2E653B7D-CC34-4AC6-8324-3F087144586BQ38659708-0E74EC24-59B6-40DA-BD7E-AB0E8CE378D0Q38697548-6BF20F4D-A611-43FA-B77C-866AE0B6181FQ39037684-3EE94A9D-3A0A-48EF-9BF0-05EDD54967E2Q39156713-A7245454-A148-4CFF-A54E-CB9E58CC830AQ39332126-914B6361-9F46-424A-AE1A-26F15F985445Q42743471-D8DFC75A-6324-4D4D-A5D1-0779FA1B732FQ47409385-33B5F023-A881-4709-84D5-04A3576A7B97Q49408164-7FCB1B7E-FB71-42D3-ADC9-52C411F84540Q51767077-A091878F-1E78-413E-90A5-B855C74C8759Q52708742-94D4F5D9-1997-42F3-92DA-0B7555F0933AQ52727302-6664EDA0-7819-464A-B32C-096AC31D2587Q52862716-5E91E1F6-8536-4DAF-A20B-87004830A91AQ58711111-E56B666C-6CE6-438A-BB2D-BAA42085683F
P2860
Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@ast
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@en
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@nl
type
label
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@ast
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@en
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@nl
prefLabel
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@ast
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@en
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@nl
P921
P356
P1476
Wnt signaling in midbrain dopa ...... dicine for Parkinson's disease
@en
P356
10.1093/JMCB/MJU001
P407
P577
2014-02-01T00:00:00Z